Used as a key intermediate in the synthesis of proteasome inhibitors, particularly in the development of anticancer agents. It plays a critical role in targeting protein degradation pathways in cells, making it valuable in research for treating diseases like multiple myeloma. Its structure enables selective binding to proteasome subunits, enhancing the potency of therapeutic compounds. Widely utilized in medicinal chemistry for designing inhibitors with improved stability and bioavailability.